XM

Xavier Mesnier

TechBio & Deeptech VC @Verve Ventures

Lausanne, Vaud

Invests in

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Partner - Head of Health & Bio investments

    2025

    Investments include: - Orakl Oncology (Fr) - Case45 (UK) - Axiom Therapeutics (UK) - Inoviv (UK) - Limula (CH) - Poppins (Fr) - Multiomic.health (UK) - Cell Voyant (UK) - Therapixel (Fr) - Cambrian Biopharma (USA)

  • Principal

    2022 - 2025

    Lead investor Techbio and Future of Computing at Verve Ventures

  • Investment Manager - France

    2020 - 2022

  • Associate

    2018 - 2019

  • Intrapreneur in Health & Bio

    2015 - 2017

2013 - 2015

  • Scientific Coordinator

    2013 - 2015

  • PhD Chemical & Biological Engineering

    2009 - 2013

2008 - 2009

  • Master thesis

    2008 - 2009

    Carried out at the Nestle Research Centre in Switzerland

2008 - 2008

  • Process Engineer

    2008 - 2008